K
Koichiro Ohmura
Researcher at Kyoto University
Publications - 184
Citations - 7612
Koichiro Ohmura is an academic researcher from Kyoto University. The author has contributed to research in topics: Rheumatoid arthritis & Medicine. The author has an hindex of 37, co-authored 157 publications receiving 6004 citations.
Papers
More filters
Journal ArticleDOI
The association between serious infection and disease outcome in patients with rheumatoid arthritis
Mikiko Iguchi-Hashimoto,Motomu Hashimoto,Takao Fujii,Masahide Hamaguchi,Moritoshi Furu,Masahiro Ishikawa,Hiromu Ito,Noriyuki Yamakawa,Chikashi Terao,Keiichi Yamamoto,Wataru Yamamoto,Koichiro Ohmura,Tsuneyo Mimori +12 more
TL;DR: Patients with a past history of serious infection that required hospitalization and the current disease status of rheumatoid arthritis had increased pulmonary and autoimmune comorbidities and were more frequently treated with glucocorticoids.
Journal ArticleDOI
Immunogenicity and lupus-like autoantibody production can be linked to each other along with type i interferon production in patients with rheumatoid arthritis treated with infliximab: A retrospective study of a single center cohort
Yuki Ishikawa,Takao Fujii,Seiko Kondo Ishikawa,Naoichiro Yukawa,Motomu Hashimoto,Moritoshi Furu,Hiromu Ito,Koichiro Ohmura,Tsuneyo Mimori +8 more
TL;DR: The development of anti-drug antibody against infliximab and lupus-like autoantibody production in patients with rheumatoid arthritis treated with inflixIMab can be linked each other along with increased l upus-associated cytokine levels including type I interferons.
Journal ArticleDOI
Successful Treatment with Tocilizumab in a Case of Intralymphatic Histiocytosis Associated with Rheumatoid Arthritis
Toshiki Nakajima,Daisuke Kawabata,Shuichiro Nakabo,Aya Miyagawa-Hayashino,Naoichiro Yukawa,Hajime Yoshifuji,Koichiro Ohmura,Takao Fujii,Tsuneyo Mimori +8 more
TL;DR: This case suggests that TCZ may be a treatment option for ILH in patients with RA and switched to tocilizumab (TCZ) treatment, which induced remission of the ILH.
Journal ArticleDOI
Anticentromere antibody-positive primary Sjögren's syndrome: Epitope analysis of a subset of anticentromere antibody-positive patients.
Noriyo Tanaka,Yoshinao Muro,Yasunori Suzuki,Susumu Nishiyama,Kunio Takada,Masahiro Sekiguchi,Naoaki Hashimoto,Koichiro Ohmura,Kumiko Shimoyama,Ichiro Saito,Mitsuhiro Kawano,Masashi Akiyama +11 more
TL;DR: Anticentromere antibody-positive pSS is proposed as a clinical subset of SS that is independent of SSc, based on the result that reactivities against CENP-C and HP1α in patients with pSS differ from those in Patients with SSc.
Journal ArticleDOI
Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis.
Shuichiro Nakabo,Shuichiro Nakabo,Koichiro Ohmura,Shuji Akizuki,Kosaku Murakami,Ran Nakashima,Motomu Hashimoto,Hajime Yoshifuji,Masao Tanaka,Tsuneyo Mimori +9 more
TL;DR: Activated neutrophils may carbamylate ambient albumin, and this is dependent on ROS and MPO, but does not require NETosis.